[Federal Register Volume 65, Number 101 (Wednesday, May 24, 2000)]
[Notices]
[Pages 33548-33552]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-13028]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 00059]


Prevention Epicenters Program; Notice of Availability of Funds

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 2000 funds for a cooperative agreement 
program for Prevention Epicenters. CDC is committed to achieving the 
health promotion and disease prevention objectives of ``Healthy People 
2010'', a national activity to reduce morbidity and mortality and 
improve the quality of life. This announcement is related to the focus 
areas of Access to Quality Health Services and Immunization and 
Infectious Diseases. For the conference copy of ``Healthy People 
2010'', visit the internet site http://www.health.gov/healthypeople.
    The purpose of the program is to assist healthcare organizations 
and institutions to support established Prevention Epicenters or to 
develop new Prevention Epicenters as part of the CDC's Prevention 
Epicenters (PE) program. The PE program is designed to develop, 
implement, and evaluate the effectiveness of epidemiologically-based 
strategies to improve healthcare quality and assure patient safety by 
preventing adverse events associated with healthcare including, but not 
limited to, healthcare-associated infections, and antimicrobial 
resistant infections. (See Attachment II Background for more 
information.)
    The goals of the PE program are to: (1) Support activities which 
lead to improvements in information system capacity to monitor 
healthcare system performance and healthcare outcomes. Such activities 
should expand the use of information technology to acquire, integrate, 
process, analyze, and report information, and use information 
technology to develop and implement innovative interventions to prevent 
infections and other adverse health events; (2) be a national resource 
for building epidemiologic capacity in healthcare outcomes research. PE 
program activities should extend the capacity of healthcare 
epidemiology and infection control programs to address patient safety, 
cost effectiveness, prevention effectiveness, healthcare outcomes 
monitoring, and performance measurement; and (3) support activities 
which develop an infrastructure to address the above goals in the 
broadest spectrum of healthcare delivery settings, including acute care 
hospitals, long-term care facilities, rehabilitation programs, dialysis 
centers, home healthcare programs, ambulatory care programs, and 
others.
    Specific objectives for the pilot and developmental phases of the 
project will include identifying (1) appropriate populations, (2) 
outcome measures, (3) data collection methods, and (4) interventions to 
be instituted in year 2 of the project.
    Each Prevention Epicenter will be established within a healthcare 
network or system, integrated healthcare delivery system (IDS), or 
managed care organization (MCO) which serves a large and diverse group 
of people. Through the network, system, or organization, the Prevention 
Epicenter should have access to patients in a variety of healthcare 
settings (e.g., long-term care, rehabilitation, home health care, 
ambulatory care, dialysis centers, etc.). The population served by the 
components of the system should be definable based on the network's, 
system's, or organization's knowledge of historical patterns of use of 
services by patients and/or the demographics of enrollment in managed 
healthcare plans served by the network, system, or organization. 
Prevention Epicenters will work together as part of a national multi-
center collaborative research and demonstration program in the areas of 
patient safety and healthcare outcomes research.

B. Eligible Applicants

    Applications may be submitted by public and private nonprofit 
organizations and by governments and their agencies; that is, 
universities, colleges, research institutions, hospitals, other public 
and private nonprofit organizations, State and local governments or 
their bona fide agents, and federally recognized Indian tribal 
governments, Indian tribes, or Indian tribal organizations.

    Note: Public Law 104-65 states that an organization described in 
section 501(c)(4) of the Internal Revenue Code of 1986 that engages 
in lobbying activities is not eligible to receive Federal funds 
constituting an award, grant, cooperative agreement, contract, loan, 
or any other form.

C. Availability of Funds

    Approximately $2,000,000 is available in FY 2000 to fund 
approximately 10 awards (up to eight competing continuations and one or 
two new Prevention Epicenters). It is expected that the average award 
for the existing Prevention Epicenters will range from approximately 
$100,000 to $450,000, depending on the activities funded per site, and 
the average award for new Prevention Epicenters will range from 
approximately $75,000 to $250,000. More funds are available for 
existing Prevention Epicenters because they are mature, fully-
functional programs and new Prevention Epicenters might need up to 12 
to 24 months to become fully-functional and able to participate in all 
activities.
    It is expected that the awards will begin on or about September 30, 
2000, and will be made for a 12-month budget period within a project 
period of up to 5 years. The funding estimate may change.
    Continuation awards within an approved project period will be made 
on the basis of satisfactory progress as evidenced by required reports 
and the availability of funds.

Funding Preferences

    1. Although applications for new programs are encouraged, funding 
preference will be given to the competing continuation applications 
over applications for programs not already receiving support under the 
existing Prevention Epicenter program. The current awardees already 
have the infrastructure needed to continue the Prevention Epicenter 
program.
    2. To achieve appropriate representation in the Prevention 
Epicenters program, funding preference may be given to approved 
applications that would enhance the racial, ethnic,

[[Page 33549]]

socioeconomic, and/or geographic diversity of the program.

D. Program Requirements

    In conducting activities to achieve the purpose of this program, 
the recipient will be responsible for the activities under 1. 
(Recipient Activities), and CDC will be responsible for the activities 
listed under 2. (CDC Activities).

1. Recipient Activities

    a. Establish and/or operate a Prevention Epicenter that is 
consistent with the purposes of the program.
    b. Establish collaborative and cooperative relationships with other 
public and private organizations that have an interest in outcomes 
research, disease management, prevention effectiveness, prevention of 
adverse health outcomes, patient safety, and healthcare quality in 
order to maximize access to, and participation of, relevant study 
populations.
    (1) Collaborate with other Prevention Epicenters to establish a PE 
program advisory committee and participate in the project planning 
activities.
    (2) Collaborate with other Prevention Epicenters on one or two core 
program activities. Core program activities are defined as activities 
intended to become multicenter collaborative projects addressing the 
three goals of the PE program.
    (3) Propose and conduct one or more investigator-initiated 
projects. Investigator initiated projects may address issues of local 
interest or concern that are in keeping with the goals of the PE 
program. In addition to focusing on defined patient populations, 
investigator-initiated projects may address issues that include, but 
are not limited to: healthcare personnel behavior modification, 
healthcare personnel safety, laboratory-based assessment and 
interventions, and the monitoring and control of antimicrobial 
resistance.
    (4) Manage, analyze, and interpret data, and publish and 
disseminate important medical and public health information stemming 
from Prevention Epicenter projects in collaboration with other PE 
program sites.
    (5) Monitor and evaluate scientific and operational accomplishments 
and progress in achieving the purpose of this program.

2. CDC Activities

    a. Collaborate, as appropriate, with the recipient in all stages of 
the program, and provide programmatic and technical assistance.
    b. As requested, participate in data collection, analysis, and 
interpretation of data from Prevention Epicenter projects. Provide 
scientific collaboration.
    c. As requested, participate in the dissemination of findings and 
information stemming from Prevention Epicenter projects.
    d. Participate in improving program performance through 
consultation based on information and activities of other projects.
    e. As requested, perform laboratory evaluation of specimens or 
isolates (e.g., molecular epidemiologic studies, evaluation of 
diagnostic tools) obtained in Prevention Epicenter projects.
    f. As requested, facilitate communication of data and results among 
Prevention Epicenters.
    g. Assist in the development of research protocols for IRB review 
by all cooperating institutions participating in the research project.
    The CDC IRB will review and approve the protocol initially and on 
at least an annual basis until the research project is completed.

E. Application Content

    Use the information in the Program Requirements, Other Requirements 
and Evaluation Criteria sections to develop the application content. 
Your application will be evaluated on the criteria listed, so it is 
important to follow them in laying out your program plan. The narrative 
should not be more than 25 single-spaced pages printed on one side, 
with one inch margins and unreduced font. Applications should follow 
the PHS 398 (rev. 4/98) application and Errata sheet, and should 
include the following information.
    1. Submission of an application for at least two but no more than 
three project activities in total. Each activity proposal, including 
the proposed multicenter collaborative projects (core program 
activities), and investigator-initiated activities, should be clearly 
identified in a distinct portion of the Operational Plan. Although the 
activities proposed may address distinct issues and needs, they may be 
implemented in an integrated manner such that staff members work on 
more than one activity, or supplies and equipment are shared.

    Note: Approximately 50-80 percent of resources will go to the 
core, multicenter collaborative activities.

    2. Provide a line-item budget and narrative justification for all 
requested costs, and separate line-item budgets for each proposal 
submitted to conduct core program activities and investigator-initiated 
activities. Budgets should be consistent with the purpose, objectives 
and research activities, and include:
    a. Line-item breakdown and justification for all personnel, i.e., 
name, position title, annual salary, percentage of time and effort, and 
amount requested.
    b. For each contract: (1) Name of proposed contractor, (2) 
breakdown and justification for estimated costs, (3) description and 
scope of activities to be performed by contractor, (4) period of 
performance, (5) method of contractor selection (e.g., sole-source or 
competitive solicitation) and (6) method of accountability.
    c. A brief five-year budget projection should be submitted that 
clearly separates and distinguishes direct from indirect costs.
    d. A description of any financial and in-kind contributions from 
nonfederal sources.
    Additionally, for each proposed activity (core and investigator-
initiated) include a one-page, single-spaced, typed abstract. The 
heading should include the title of the cooperative agreement, project 
title, organization, name and address, project director, and telephone 
number. This abstract should include a workplan identifying activities 
to be developed, activities to be completed, and a time-line for 
completion of these activities.

F. Submission and Deadline

Letter of Intent

    In order to enable CDC to determine the level of interest in the 
program announcement, a non-binding letter-of-intent to apply is 
requested from potential applicants. Your letter-of-intent should 
identify program announcement number 00059, and include the following 
information: (1) Name and address of institution, and (2) name, 
address, telephone number, e-mail address, and fax number of contact 
person. On or before June 9, 2000, submit the letter-of-intent 
(original and two copies) to the Grants Management Specialist 
identified in the ``Where to Obtain Additional Information'' section of 
this announcement.

Application

    Submit the original and five copies of PHS 398 (OMB Number 0925-
0001) and adhere to the instructions on the Errata Instruction Sheet 
for PHS 398). Forms are in the application kit.
    On or before July 11, 2000, submit the application to the Grants 
Management Specialist identified in the ``Where to Obtain Additional 
Information Section of this announcement.
    Deadline: Applications shall be considered as meeting the deadline 
if they are either:

[[Page 33550]]

    (a) Received on or before the deadline date; or
    (b) Sent on or before the deadline date and received in time for 
submission to the independent review group. (Applicants must request a 
legibly dated U.S. Postal Service postmark or obtain a legibly dated 
receipt from a commercial carrier or U.S. Postal Service. Private 
metered postmarks shall not be acceptable as proof of timely mailing.)
    Late Applications: Applications which do not meet the criteria in 
(a) or (b) above are considered late applications, will not be 
considered, and will be returned to the applicant.

G. Evaluation Criteria

    Each competing continuation Prevention Epicenter and new 
application will be evaluated individually against the following 
criteria by an independent review group appointed by CDC.

Competing Continuation PE Centers

1. Establishment of Prevention Epicenter (30 points)
a. Productivity
    Extent to which the competing continuation Center has used program 
resources to successfully conduct research and demonstration projects 
as evidenced by submission of abstracts to national scientific 
meetings; presentations at local, regional and national conferences, 
meetings, and other settings for information exchange; and publications 
in scientific journals, lay media, public or healthcare provider 
information and educational sources.
b. Institutionalization
    Extent to which the Prevention Epicenter has been established 
within the home institution and network/system/organization as 
evidenced by collaboration with other departments, institutions, and 
components of the network/system/organization; support from officials 
and representatives of the home institution and networks; recognition 
in internal publications and documents; and collaboration as a 
Prevention Epicenter with entities outside the network/system/
organization.
2. Existing Capacity (30 points)
    Description of existing capacity to conduct outcomes research and 
prevention effectiveness research in the areas of healthcare-associated 
infections and other adverse events associated with healthcare.
    a. Description of applicant's experience and documentation of 
accomplishments in conducting healthcare outcomes research and quality 
improvement activities, including projects and studies involving: 
database integration; outcomes data acquisition, validation, and 
analysis; cost-and resource-effectiveness and cost-utility assessment; 
performance measurement and performance improvement; quality of care 
assessment and intervention clinical and laboratory process and 
outcomes assessment; and provider and patient behavior change studies 
and interventions. (A list of relevant papers and abstracts should be 
included in an appendix.)
    b. Description of applicant's experience and documentation of 
accomplishments in conducting surveillance, applied epidemiologic 
research, applied laboratory research, and prevention research in the 
areas of healthcare-associated infections and other adverse events 
(e.g., antimicrobial drug resistant infections, device-related 
infections, medication errors, etc.) A list of relevant papers and 
abstracts should be included in an appendix.
    c. Demonstration of applicant's ability to develop and maintain 
strong cooperative relationships with medical, public health, 
laboratory, academic, and community organizations that are either 
public or private, local or regional. Evidence of applicant's ability 
to solicit and secure programmatic collaboration, and financial and 
technical support from such organizations.
    d. Demonstration of support from non-applicant participating 
agencies, institutions, organizations, laboratories, individuals, 
consultants, etc., mentioned in the operational plan. Applicant should 
provide (in an appendix) letters of support which clearly indicate each 
collaborator's willingness to participate in studies and other 
activities with the Prevention Epicenter. The letters should clearly 
define the roles of these collaborations.
    e. Demonstration of applicant's ability to participate in 
multicenter research and demonstration studies.
3. Operational Plan (35 points)
    a. The extent to which the applicant's plan for establishing, 
operating, and maintaining the Prevention Epicenter clearly describes 
the proposed activities and clearly identifies the roles and 
responsibilities of all participating individuals, agencies, 
organizations, and institutions.
    b. The extent to which the applicant describes plans for 
collaboration with other PE program sites in the establishment and 
operation of the PE program and individual Prevention Epicenter 
projects, including participation in advisory committee and 
subcommittee activities, as well as project design/development (e.g., 
protocols), management and analysis of data, and synthesis and 
dissemination of findings.
    c. Description and quality of applicant's partnerships with 
necessary and appropriate individuals, departments, agencies and 
organizations for establishing and operating the proposed Prevention 
Epicenter projects.
    d. Consistency of the proposed projects with regard to Prevention 
Epicenter program goals.
    e. Description of the operational plan for conducting core 
multicenter collaborative projects, including the extent to which: (1) 
The project is consistent with one or more of the stated goals of the 
PE program, (2) the objectives of the proposed project are specific, 
measurable, and time-phased; (3) the plan clearly describes applicant's 
technical approach/methods for conducting the proposed project(s); and 
(4) the plan is adequate to accomplish the stated objectives.
    f. Description of the operational plan for conducting one or two 
investigator-initiated projects, including the extent to which: (1) The 
project is consistent with one or more of the stated goals of the PE 
program, (2) the objectives of the proposed project are specific, 
measurable, and time-phased; (3) the plan clearly describes applicant's 
technical approach/methods for conducting the proposed project(s); and 
(4) the plan is adequate to accomplish the stated objectives.
    g. Identification of applicant's key professional personnel to be 
assigned to the Prevention Epicenter and to specific projects as well 
as key professional personnel from other participating or collaborating 
institutions, agencies, organizations outside of the applicant's agency 
that will be assigned to PE activities (provide curriculum vitae for 
each in an appendix). Clear identification of applicants' respective 
roles in the management and operation of the Prevention Epicenter and 
in individual projects. Descriptions of participants' experience in 
conducting work similar to that proposed in this announcement.
    h. Description of all support staff and services to be assigned to 
the Prevention Epicenter.
    i. The degree to which the applicant has met the CDC Policy 
requirements regarding the inclusion of women, ethnic, and racial 
groups in the proposed research. This includes (1) the proposed plan 
for the inclusion of both sexes and racial and ethnic minority

[[Page 33551]]

populations for appropriate representation, (2) the proposed 
justification when representation is limited or absent, (3) a statement 
as to whether the design of the study is adequate to measure 
differences when warranted and (4) a statement as to whether the plans 
for recruitment and outreach for study participants include the process 
of establishing partnerships with community(ies) and recognition of 
mutual benefits.
4. Evaluation (5 points)
    a. Quality of plan for monitoring and evaluating scientific and 
operational accomplishments of the Prevention Epicenter and of 
individual Center projects.
    b. Quality of plan for monitoring and evaluating progress in 
achieving the purpose and overall goals of this cooperative agreement 
program.
5. Budget (not scored)
    Extent to which the line-item budget is detailed, clearly 
justified, and consistent with the purpose and objectives of this 
program.
6. Human Subjects (not scored)
    Does the application adequately address the requirements of Title 
45 CFR part 46 for the protection of human subjects?

New Applicants

1. Understanding the objectives of the PE program (5 points)
    a. Demonstration of a clear understanding of the background and 
objectives of this cooperative agreement program.
    b. Demonstration of a clear understanding of the requirements, 
responsibilities, problems, constraints, and complexities that may be 
encountered in establishing and operating the Prevention Epicenter.
    c. Demonstration of a clear understanding of the roles and 
responsibilities of participation in the PE program.
2. Description of the healthcare network or system, IDS, or MCO in 
which the Prevention Epicenter is situated and the population served by 
the network/system/organization (10 points)
    a. Clear definition of the components of the network/system/
organization, their relationship to the Prevention Epicenter, the 
geographic area and the population base in which the Prevention 
Epicenter will operate.
    b. Clear description of the populations served, the health care 
services provided, and the healthcare settings within which defined 
population(s) receive care, as they relate to the proposed activities 
of the PE program.
    c. Clear description of the management information systems of the 
network/system/organization, with emphasis on the level of integration 
of patient level electronic data sources within and between facilities, 
including electronic data bases containing clinical, administrative, 
laboratory, pharmacy, and other data. Description of the availability 
and accessibility of such data for outcomes-type research.
    d. Extent to which the population base is diverse demographically.
3. Description of existing capacity to conduct outcomes research and 
prevention effectiveness research in the areas of healthcare-associated 
infections and other adverse events associated with healthcare (35 
points)
    a. Description of applicant's experience and documentation of 
accomplishments in conducting healthcare outcomes research and quality 
improvement activities, including projects and studies involving: 
database integration; outcomes data acquisition, validation, and 
analysis; cost- and resource-effectiveness and cost-utility assessment; 
performance measurement and performance improvement; quality of care 
assessment and intervention clinical and laboratory process and 
outcomes assessment; and provider and patient behavior change studies 
and interventions. (A list of relevant papers and abstracts should be 
included in an appendix.)
    b. Description of applicant's experience and documentation of 
accomplishments in conducting surveillance, applied epidemiologic 
research, applied laboratory research, and prevention research in the 
areas of healthcare-associated infections and other adverse events 
(e.g., antimicrobial drug resistant infections, device-related 
infections, medication errors, etc.) A list of relevant papers and 
abstracts should be included in an appendix.
    c. Demonstration of applicant's ability to develop and maintain 
strong cooperative relationships with medical, public health, 
laboratory, academic, and community organizations that are either 
public or private, local or regional. Evidence of applicant's ability 
to solicit and secure programmatic collaboration, and financial and 
technical support from such organizations.
    d. Demonstration of support from non-applicant participating 
agencies, institutions, organizations, laboratories, individuals, 
consultants, etc., mentioned in the operational plan. Applicant should 
provide (in an appendix) letters of support which clearly indicate each 
collaborator's willingness to participate in studies and other 
activities with the Prevention Epicenter. The letters should clearly 
define the roles of these collaborations.
    e. Demonstration of applicant's ability to participate in 
multicenter research and demonstration studies.
4. Operational Plan (45 points)
    a. The extent to which the applicant's plan for establishing, 
operating, and maintaining the Prevention Epicenter clearly describes 
the proposed activities and clearly identifies the roles and 
responsibilities of all participating individuals, agencies, 
organizations, and institutions.
    b. The extent to which the applicant describes plans for 
collaboration with other PE program sites in the establishment and 
operation of the PE program and individual Prevention Epicenter 
projects, including participation in advisory committee and 
subcommittee activities, as well as project design/development (e.g., 
protocols), management and analysis of data, and synthesis and 
dissemination of findings.
    c. Description and quality of applicant's partnerships with 
necessary and appropriate individuals, departments, agencies and 
organizations for establishing and operating the proposed Prevention 
Epicenter projects.
    d. Consistency of the proposed projects with regard to Prevention 
Epicenter goals.
    e. Description of the operational plan for conducting core 
multicenter collaborative projects, including the extent to which: (1) 
the project is consistent with one or more of the stated goals of the 
PE program, (2) the objectives of the proposed project are specific, 
measurable, and time-phased; (3) the plan clearly describes applicant's 
technical approach/methods for conducting the proposed project(s); and 
(4) the plan is adequate to accomplish the stated objectives.
    f. Description of the operational plan for conducting one or two 
investigator-initiated projects, including the extent to which: (1) The 
project is consistent with one or more of the stated goals of the PE 
program, (2) the objectives of the proposed project are specific, 
measurable, and time-phased; 3) the plan clearly describes applicant's 
technical approach/methods for conducting the proposed project(s); and 
(4) the plan is adequate to accomplish the stated objectives.
    g. Identification of applicant's key professional personnel to be 
assigned to the Prevention Epicenter and to specific

[[Page 33552]]

projects as well as key professional personnel from other participating 
or collaborating institutions, agencies, organizations outside of the 
applicant's agency that will be assigned to PE activities (provide 
curriculum vitae for each in an appendix). Clear identification of 
applicants' respective roles in the management and operation of the 
Prevention Epicenter and in individual projects. Descriptions of 
participants' experience in conducting work similar to that proposed in 
this announcement.
    h. Description of all support staff and services to be assigned to 
the Prevention Epicenter.
    i. The degree to which the applicant has met the CDC Policy 
requirements regarding the inclusion of women, ethnic, and racial 
groups in the proposed research. This includes (a) the proposed plan 
for the inclusion of both sexes and racial and ethnic minority 
populations for appropriate representation, (b) the proposed 
justification when representation is limited or absent, (c) a statement 
as to whether the design of the study is adequate to measure 
differences when warranted and (d) a statement as to whether the plans 
for recruitment and outreach for study participants include the process 
of establishing partnerships with community(ies) and recognition of 
mutual benefits.
5. Evaluation (5 points)
    a. Quality of plan for monitoring and evaluating scientific and 
operational accomplishments of the Prevention Epicenter and of 
individual Center projects.
    b. Quality of plan for monitoring and evaluating progress in 
achieving the purpose and overall goals of this cooperative agreement 
program.
6. Budget (not scored)
    Extent to which the line-item budget is detailed, clearly 
justified, and consistent with the purpose and objectives of this 
program.
7. Human Subjects (not scored)
    Does the application adequately address the requirements of Title 
45 CFR part 46 for the protection of human subjects?

H. Other Requirements

Technical Reporting Requirements

    Provide CDC with original plus two copies of
    1. progress reports (semiannual);
    2. financial status report, no more than 90 days after the end of 
the budget period; and
    3. final financial status and performance reports, no more than 90 
days after the end of the project period.
    Send all reports to the Grants Management Specialist identified in 
the ``Where To Obtain Additional Information'' section of this 
announcement.
    The following additional requirements are applicable to this 
program. For a complete description of each, see Attachment I in the 
application kit.
AR-1  Human Subjects Requirements
AR-2  Requirements for Inclusion of Women and Racial and Ethnic 
Minorities in Research
AR-7  Executive Order 12372 Review
AR-9  Paperwork Reduction Act Requirements
AR-10  Smoke-Free Workplace Requirements
AR-11  Healthy People 2010
AR-12  Lobbying Restrictions
AR-15  Proof of Non-Profit Status

I. Authority and Catalog of Federal Domestic Assistance Number

    This program is authorized under section 301(a) and 317(k)(2) of 
the Public Health Service Act, [42 U.S.C. sections 241(a) and 
247b(k)(2)], as amended. The Catalog of Federal Domestic Assistance 
number is 93.283.

J. Where to Obtain Additional Information

    For this and other CDC announcements, please see the CDC home page 
on the Internet: http://www.cdc.gov (click on ``Funding''). To receive 
additional written information and to request an application kit, call 
1-888-GRANTS4 (1-888 472-6874). You will be asked to leave your name 
and address and will be instructed to identify the Announcement number 
of interest.
    If you have questions after reviewing the contents of all the 
documents, business management technical assistance may be obtained 
from: Gladys Gissentanna, Grants Management Specialist, Grants 
Management Branch, Procurement and Grants Office, Centers for Disease 
Control and Prevention, 2920 Brandywine Road, Room 3000, Atlanta, GA 
30341-4146, Telephone number 770-488-2753, Email address <a href="/cdn-cgi/l/email-protection#6403070350240700074a030b12"><span class="__cf_email__" data-cfemail="f2959195c6b2919691dc959d84">[email protected]</span></a>
    For program technical assistance, contact: Steve Solomon, M.D., 
Hospital Infections Program, National Center for Infectious Diseases, 
Centers for Disease Control and Prevention, 1600 Clifton Road, N.E. 
Mailstop A-07, Atlanta, GA 30333, Telephone number 404-639-6476, Email 
address <a href="/cdn-cgi/l/email-protection#88fbe4fbb9c8ebeceba6efe7fe"><span class="__cf_email__" data-cfemail="94e7f8e7a5d4f7f0f7baf3fbe2">[email protected]</span></a>

    Dated: May 18, 2000.
John L. Williams,
Director, Procurement and Grants Office, Centers for Disease Control 
and Prevention (CDC).
[FR Doc. 00-13028 Filed 5-23-00; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>